Cyclosporine combined with Ondansetron

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Oxygen Saturation Decreased Other Serious 32 Female 132 lb 3/9/2006 United States
Primary
Concomitant
Oxygen Saturation Decreased Other Serious 32 Female 132 lb 3/6/2006 United States
Primary
Secondary
Concomitant
Methaemoglobinaemia Hospitalization 1/1/2005 32 Female 3/29/2006 Physician United States
Primary
Secondary
Concomitant
Vomiting Other Serious 3 Male 11/6/2006
Primary
Concomitant
Pancreatitis Haemorrhagic Hospitalization 5 Female 1/9/2007 Consumer Australia
Primary
Secondary
Concomitant
Pancreatitis Acute Other Serious 10 Male 1/12/2007 Physician Australia
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 9 Male 7/10/2007 Other Health Professional Sweden
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 9 Male 8/3/2007 Other Health Professional Sweden
Primary
Concomitant
Toxic Epidermal Necrolysis Required Intervention 10 Male 9/17/2007 Other Health Professional Sweden
Primary
Secondary
Concomitant
Tongue Disorder Other Serious 14 Male 10/17/2007 Other Health Professional United States
Primary
Concomitant
Venoocclusive Disease Other Serious 9/19/2007 Female 137 lb 11/2/2007 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Disease Life Threatening 9/19/2007 19 Female 11/19/2007 Consumer United Kingdom
Primary
Secondary
White Blood Cell Count Decreased Hospitalization 10 Male 11/8/2007 Sweden
Primary
Secondary
Concomitant
Dilatation Intrahepatic Duct Acquired Life Threatening 9/19/2007 19 Female 11/21/2007 United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 11/21/2007 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Disease Other Serious 9/19/2007 19 Female 11/26/2007 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 11/27/2007 Other Health Professional United Kingdom
Primary
Secondary
Dilatation Intrahepatic Duct Acquired Life Threatening 9/19/2007 19 Female 11/26/2007 United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 19 Female 11/27/2007 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 9/19/2007 19 Female 11/26/2007 United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 19 Female 11/30/2007 Pharmacist United Kingdom
Primary
Concomitant
Toxic Epidermal Necrolysis Other Serious 10 Male 12/14/2007 Sweden
Primary
Secondary
Concomitant
Venoocclusive Disease Other Serious 9/19/2007 Female 137 lb 12/26/2007 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Thrombotic Thrombocytopenic Purpura Death 9/24/2007 46 Female 146 lb 1/24/2008 United Kingdom
Primary
Concomitant
Stem Cell Transplant Hospitalization 5/12/2008 60 Female 200 lb 7/14/2008 Physician United States
Primary
Secondary
Concomitant
Gingival Hyperplasia Hospitalization 7/20/2008 Male 8/7/2008 Physician United States
Primary
Secondary
Concomitant
Vomiting Other Serious 5/19/2008 Male 52 lb 8/15/2008 Other Health Professional Brazil
Primary
Secondary
Concomitant
Gingival Hyperplasia Hospitalization 7/20/2008 Male 8/21/2008 Physician United States
Primary
Secondary
Concomitant
Thrombosis Hospitalization 8/4/2005 15 Male 159 lb 9/26/2008 Physician United States
Primary
Concomitant
Vomiting Other Serious 5/19/2008 Male 52 lb 10/16/2008 Other Health Professional Brazil
Primary
Secondary
Concomitant
Renal Failure Hospitalization 8/4/2005 15 Male 159 lb 11/18/2008 Physician United States
Primary
Concomitant
Gingival Hyperplasia 7/20/2008 Male 11/24/2008 Physician United States
Primary
Secondary
Concomitant
Oesophagitis Hospitalization 6/9/2008 60 Male 249 lb 12/22/2008 Physician United States
Primary
Secondary
Concomitant
Toxic Epidermal Necrolysis Other Serious 11/28/2008 Female 163 lb 2/6/2009 Germany
Primary
Secondary
Concomitant
Venoocclusive Disease Other Serious 9/19/2007 19 Female 2/23/2009 Other Health Professional United Kingdom
Primary
Secondary
Renal Failure Hospitalization 8/4/2005 15 Male 159 lb 3/13/2009 Physician United States
Primary
Concomitant
Urinary Retention Other Serious 1/29/2009 65 Female 119 lb 4/6/2009 Germany
Primary
Concomitant
Infusion Site Swelling Other Serious 4/28/2009 55 Male 177 lb 4/30/2009 Pharmacist United States
Primary
Concomitant
Application Site Discolouration 5/6/2009 1 Female 13 lb 5/6/2009 Pharmacist United States
Primary
Concomitant
Transplant Rejection Hospitalization 4/9/2009 Male 56 lb 5/27/2009 United States
Primary
Concomitant
Pancreatitis Haemorrhagic Other Serious 5 Female 7/16/2009 Other Health Professional Australia
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization 6/24/2009 48 Female 237 lb 7/29/2009 Physician Australia
Primary
Concomitant
Renal Failure Acute Other Serious 5/1/2009 61 Male 8/10/2009 Other Health Professional United States
Primary
Concomitant
Small Intestine Ulcer Other Serious 5/1/2009 61 Male 8/19/2009 Physician United States
Primary
Concomitant
Stem Cell Transplant Other Serious 10/12/2008 Female 12 lb 8/31/2009 Physician United Kingdom
Primary
Concomitant
Graft Versus Host Disease Death 9/9/2008 Male 168 lb 9/9/2009 Physician United Kingdom
Primary
Concomitant
Plasmacytoma Hospitalization 8/16/2009 64 Male 9/11/2009 Other Health Professional United States
Primary
Concomitant
Stem Cell Transplant Other Serious 8/16/2009 64 Male 9/21/2009 Physician United States
Primary
Secondary
Concomitant
Sepsis Other Serious 5/1/2009 61 Male 9/14/2009 Physician United States
Primary
Concomitant
Plasmacytoma Hospitalization 8/16/2009 64 Male 9/24/2009 Other Health Professional United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 6/24/2009 48 Female 237 lb 10/7/2009 Other Health Professional Australia
Primary
Concomitant
Stem Cell Transplant Other Serious 10/12/2008 Female 12 lb 10/22/2009 Other Health Professional United Kingdom
Primary
Concomitant
Tremor Hospitalization 8/16/2009 64 Male 11/23/2009 Other Health Professional United States
Primary
Concomitant
Oesophagitis Other Serious 11/9/2009 Female 128 lb 12/11/2009 Physician United States
Primary
Secondary
Concomitant
Oesophagitis Other Serious 11/9/2009 Female 128 lb 12/23/2009 Physician United States
Primary
Secondary
Concomitant
Tremor Hospitalization 8/16/2009 64 Male 12/21/2009 Physician United States
Primary
Concomitant
Multi-organ Failure Death 12/26/2009 56 Male 203 lb 1/8/2010 Physician Germany
Primary
Secondary
Concomitant
Multi-organ Failure Death 12/26/2009 56 Male 203 lb 1/12/2010 Physician Germany
Primary
Secondary
Concomitant
Systemic Candida Other Serious 11/9/2009 Female 128 lb 1/15/2010 Physician United States
Primary
Secondary
Concomitant
Vascular Test Abnormal Hospitalization 10/6/2009 89 Female 2/17/2010 Physician United States
Primary
Concomitant
Vascular Test Abnormal Hospitalization 10/6/2009 89 Female 2/17/2010 Physician United States
Primary
Concomitant
Tachycardia Life Threatening 3/3/2010 45 Female 240 lb 3/26/2010 Consumer United Kingdom
Primary
Concomitant
Venoocclusive Liver Disease Life Threatening Female 8/30/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 9/7/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/7/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 9/19/2007 19 Female 9/9/2010 Consumer United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening Female 9/9/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/19/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/10/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 19 Female 9/10/2010 Consumer United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Dilatation Intrahepatic Duct Acquired Other Serious 1/1/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 9/19/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Dilatation Intrahepatic Duct Acquired Other Serious 1/1/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 9/19/2007 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/19/2007 19 Female 9/13/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 9/14/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/14/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 22 Female 9/9/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 19 Female 9/15/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 22 Female 9/16/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/10/2010 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Liver Disease Other Serious 9/19/2007 19 Female 9/16/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/9/2010 Consumer United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 137 lb 9/17/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/20/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/19/2007 19 Female 9/20/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 9/19/2007 19 Female 9/21/2010 Other Health Professional United Kingdom
Primary
Secondary
Dilatation Intrahepatic Duct Acquired Other Serious 1/1/2007 19 Female 9/21/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/19/2007 9/22/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/17/2010 Other Health Professional
Primary
Secondary
Venoocclusive Liver Disease Life Threatening 19 Female 9/23/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/22/2010 Other Health Professional
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/28/2010 Pharmacist United Kingdom
Primary
Secondary
Venoocclusive Disease Other Serious 19 Female 9/20/2010 Other Health Professional Denmark
Primary
Secondary
Venoocclusive Disease Other Serious 19 Female 9/24/2010 Other Health Professional Denmark
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 9/27/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 9/19/2007 10/1/2010 Other Health Professional United Kingdom
Primary
Secondary
Venoocclusive Liver Disease Other Serious 19 Female 10/1/2010 Other Health Professional
Primary
Secondary
Urinary Retention Other Serious 1/29/2009 65 Female 119 lb 9/28/2010 Other Health Professional Germany
Primary
Secondary
Concomitant
Pulmonary Haemorrhage Life Threatening 2/8/2010 15 Female 110 lb 10/15/2010 Other Health Professional Germany
Primary
Secondary
Concomitant
Osteomalacia Hospitalization 7/20/2010 64 Female 88 lb 10/21/2010 Physician United States
Primary
Concomitant
Aspartate Aminotransferase Increased Other Serious 9/7/2009 5 Male 38 lb Other Health Professional United States
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Other Serious 6/24/2009 49 Female 237 lb 10/26/2010 Other Health Professional Australia
Primary
Concomitant
Alanine Aminotransferase Increased Life Threatening 9/19/2007 19 Female 1/25/2011 United Kingdom
Primary
Secondary
Alanine Aminotransferase Increased Other Serious 1/1/2007 19 Female 137 lb 2/21/2011 Other Health Professional United Kingdom
Primary
Secondary
Acute Graft Versus Host Disease Death 3/4/2011 Physician Mexico
Primary
Secondary
Concomitant
Sepsis Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Acute Graft Versus Host Disease Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Acute Graft Versus Host Disease Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Sepsis Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Pneumonia Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Pneumonia Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Pulmonary Toxicity Death 3/7/2011 Physician Mexico
Primary
Secondary
Concomitant
Blood Alkaline Phosphatase Increased Other Serious 19 Female 3/2/2011 Other Health Professional
Primary
Secondary
Pyrexia Other Serious 8/1/2008 Male 3/15/2011 Lawyer United States
Primary
Secondary
Concomitant
Hypertonia Disability 1/21/2011 Male 11 lb 3/16/2011 Physician United Kingdom
Primary
Secondary
Concomitant
Hypertonia Disability 1/21/2011 0 Male 11 lb 3/15/2011 Other Health Professional United Kingdom
Primary
Concomitant
Hypertonia Disability 1/21/2011 0 Male 11 lb 3/11/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Convulsion Disability 1/21/2011 0 Male 3/15/2011 Physician Denmark
Primary
Secondary
Concomitant
Nausea Other Serious 8/1/2008 Male 4/8/2011 Lawyer United States
Primary
Secondary
Concomitant
Asthma Other Serious 3/19/2011 51 Female 228 lb 4/19/2011 Physician United Kingdom
Primary
Concomitant
Acute Graft Versus Host Disease In Intestine Hospitalization 4/9/2011 42 Female 197 lb 4/28/2011 Consumer United States
Primary
Secondary
Concomitant
Acute Graft Versus Host Disease In Intestine Hospitalization 4/9/2011 42 Female 197 lb 5/15/2011 Physician United States
Primary
Secondary
Concomitant
Bursitis Hospitalization 8/1/2008 43 Male 5/19/2011 Physician United States
Primary
Secondary
Concomitant
Bone Marrow Disorder Hospitalization 8/1/2008 43 Male 6/27/2011 Lawyer United States
Primary
Secondary
Concomitant
Hallucination Other Serious 6/19/2011 17 Female 184 lb 6/23/2011 Physician United States
Primary
Concomitant
Diabetic Ketoacidosis Hospitalization 8/1/2008 43 Male 166 lb 6/30/2011 Physician United States
Primary
Secondary
Concomitant
Hepatotoxicity Life Threatening 9/19/2007 19 Female 7/21/2011 Consumer United Kingdom
Primary
Secondary
Concomitant
Liver Function Test Abnormal Life Threatening 9/19/2007 19 Female 7/21/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Blood Triglycerides Increased Other Serious 6/6/2011 23 Female 95 lb 6/10/2011 Other Health Professional United States
Primary
Concomitant
Pyrexia Other Serious 7/31/2011 29 Female 159 lb 8/15/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Hypotension Other Serious 12/3/2007 54 Male 249 lb 11/25/2008 Consumer United States
Primary
Concomitant
Localised Infection Other Serious 8/1/2008 43 Male 166 lb 8/29/2011 Lawyer United States
Primary
Secondary
Concomitant
Aspartate Aminotransferase Increased Hospitalization 8/29/2011 28 Male 137 lb 9/12/2011 Other Health Professional United States
Primary
Concomitant
Cough Hospitalization 1/1/2010 55 Female 134 lb 9/22/2011 Physician Australia
Primary
Concomitant
Haematuria Other Serious 1/1/2011 21 Female 119 lb 9/23/2011 Pharmacist Brazil
Primary
Concomitant
Lung Consolidation Other Serious 1/19/2011 3 Male 35 lb 9/27/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Liver Disease Death 1/24/2011 3 Male 33 lb 9/29/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Periorbital Oedema Life Threatening 1/27/2011 6 Female 40 lb 10/3/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Cytomegalovirus Infection Life Threatening 1/19/2011 3 Male 35 lb 10/3/2011 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Deep Vein Thrombosis Death 12/7/2010 6 Female 40 lb 10/4/2011 Pharmacist United Kingdom
Primary
Secondary
Concomitant
Hypertension Other Serious 6/12/2010 53 Male 154 lb 10/5/2011 Physician Japan
Primary
Concomitant
Pneumonia Death 6/24/2009 49 Female 237 lb 9/19/2011 Other Health Professional Australia
Primary
Concomitant
Venoocclusive Liver Disease Death 1/24/2011 3 Male 35 lb 10/4/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Liver Disease Other Serious 1/1/2011 4 Male 37 lb 10/11/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Febrile Neutropenia Life Threatening 6 Female 40 lb 10/6/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Liver Disease Death 1/24/2011 3 Male 33 lb 10/18/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Haematemesis Other Serious 4 Male 38 lb 10/14/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Venoocclusive Liver Disease Death 1/24/2011 3 Male 35 lb 10/18/2011 Other Health Professional United Kingdom
Primary
Secondary
Concomitant

Drug Data